Showing 3801-3810 of 9118 results for "".
A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.New Products and Pharmacologic Developments
https://practicaldermatology.com/topics/general-topics/new-products-and-pharmacologic-developments/22949/New products and pharmacologic developmentsNew Findings Raise Questions About EHRs Going Forward
https://practicaldermatology.com/topics/practice-management/new-findings-raise-questions-about-ehrs-going-forward/22934/A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22923/Protect Your Data. Protect Yourself
https://practicaldermatology.com/topics/practice-management/protect-your-data-protect-yourself/22906/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21558/James A. Solomon, MD, PhD
https://practicaldermatology.com/topics/general-topics/james-a-solomon-md-phd/21559/Examining the Implications of Stage 2 of the EHR Incentive Program
https://practicaldermatology.com/topics/practice-management/examining-the-implications-of-stage-2-of-the-ehr-incentive-program/21564/Requirements for patient involvement via portals may spell headaches for physicians hoping to qualify for government incentives in 2014.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21616/New products and pharmacologic developmentsAn Overview of Topical Acne Therapy
https://practicaldermatology.com/issues/supplements/an-overview-of-topical-acne-therapy/21619/It's important to recall the rationale for topical therapy, its occasional limitations, and its potential to benefit a majority of acne patients.